[Skip to Content]
[Skip to Content Landing]
Views 140
Citations 0
Comment & Response
November 2017

Intensive Blood Pressure Control in Autosomal Dominant Polycystic Kidney Disease—How Safe Is It?—Reply

Author Affiliations
  • 1Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei City, Taiwan
  • 2Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan
  • 3Department of Marketing and Distribution Management, Oriental Institute of Technology, New Taipei City, Taiwan
  • 4Department of Internal Medicine, National Taiwan University Hospital and College of Medicine, Taipei, Taiwan
  • 5Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan
JAMA Intern Med. 2017;177(11):1695-1696. doi:10.1001/jamainternmed.2017.4925

In Reply We would like to thank Drs Ardalan and Golzari for their opinions concerning intensive blood pressure (BP) control in patients with autosomal dominant polycystic kidney disease (ADPKD). Hypertension is common, occurs early, and is associated with the loss of renal function in patients with ADPKD.1,2 Despite the importance of BP control in patients with chronic kidney disease, the role of intensive BP-lowering strategy in delaying the progression of ADPKD is not clear.

×